8839930|t|Vitamin E in humans: demand and delivery.
8839930|a|How much vitamin E is enough? An established use of supplemental vitamin E in humans is in the prevention and therapy of deficiency symptoms. The cause of vitamin E deficiency, characterized by peripheral neuropathy and ataxia, is usually malabsorption-a result of fat malabsorption or genetic abnormalities in lipoprotein metabolism. Genetic abnormalities in the hepatic alpha-tocopherol transfer protein also cause vitamin E deficiency-defects in this protein cause an impairment in plasma vitamin E transport. Impaired delivery of vitamin E to tissues, thereby, results in deficiency symptoms. Also discussed is the use of supplemental vitamin E in chronic diseases such as ischemic heart disease, atherosclerosis, diabetes, cataracts, Parkinson's disease, Alzheimer's disease, and impared immune function, as well as in subjects receiving total parenterol nutrition. In healthy individuals, a daily intake of about 15-30 mg of alpha-tocopherol is recommended to obtain "optimal plasma alpha-tocopherol concentrations" (30 microM or greater).
8839930	0	9	Vitamin E	Chemical	MESH:D014810
8839930	13	19	humans	Species	9606
8839930	51	60	vitamin E	Chemical	MESH:D014810
8839930	107	116	vitamin E	Chemical	MESH:D014810
8839930	120	126	humans	Species	9606
8839930	163	182	deficiency symptoms	Disease	MESH:D012816
8839930	197	217	vitamin E deficiency	Disease	MESH:D014811
8839930	236	257	peripheral neuropathy	Disease	MESH:D010523
8839930	262	268	ataxia	Disease	MESH:D001259
8839930	281	294	malabsorption	Disease	MESH:D008286
8839930	307	324	fat malabsorption	Disease	MESH:D008286
8839930	328	349	genetic abnormalities	Disease	MESH:D030342
8839930	377	398	Genetic abnormalities	Disease	MESH:D030342
8839930	414	447	alpha-tocopherol transfer protein	Gene	7274
8839930	534	543	vitamin E	Chemical	MESH:D014810
8839930	576	585	vitamin E	Chemical	MESH:D014810
8839930	618	637	deficiency symptoms	Disease	MESH:D012816
8839930	681	690	vitamin E	Chemical	MESH:D014810
8839930	694	710	chronic diseases	Disease	MESH:D002908
8839930	719	741	ischemic heart disease	Disease	MESH:D017202
8839930	743	758	atherosclerosis	Disease	MESH:D050197
8839930	760	768	diabetes	Disease	MESH:D003920
8839930	770	779	cataracts	Disease	MESH:D002386
8839930	781	800	Parkinson's disease	Disease	MESH:D010300
8839930	802	821	Alzheimer's disease	Disease	MESH:D000544
8839930	891	901	parenterol	Chemical	-
8839930	973	989	alpha-tocopherol	Chemical	MESH:D024502
8839930	1031	1047	alpha-tocopherol	Chemical	MESH:D024502
8839930	Negative_Correlation	MESH:D014810	MESH:D050197
8839930	Negative_Correlation	MESH:D014810	MESH:D012816
8839930	Association	MESH:D030342	7274
8839930	Negative_Correlation	MESH:D014810	MESH:D003920
8839930	Negative_Correlation	MESH:D014810	MESH:D017202
8839930	Negative_Correlation	MESH:D014810	MESH:D010300
8839930	Negative_Correlation	MESH:D014810	MESH:D002908
8839930	Negative_Correlation	MESH:D014810	MESH:D000544
8839930	Negative_Correlation	MESH:D014810	MESH:D002386
8839930	Association	MESH:D014810	7274

